Skip to main content
. 2012 May;97(5):751–757. doi: 10.3324/haematol.2011.047670

Figure 2.

Figure 2.

Progression-free survival (solid line) and overall survival (dotted line) of the 19 patients receiving mini-BEAM. Because ten patients developed progressive disease immediately after mini-BEAM, the progression-free survival curve does not begin at 1.0.